Venus Concept Inc. (NASDAQ:VERO) Short Interest Up 258.6% in April

Venus Concept Inc. (NASDAQ:VERO) was the target of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 158,500 shares, a growth of 258.6% from the March 31st total of 44,200 shares. Based on an average trading volume of 1,140,000 shares, the short-interest ratio is currently 0.1 days. Currently, 43.9% of the company’s shares are sold short.

Venus Concept Stock Performance

NASDAQ:VERO opened at $2.48 on Monday. The company has a debt-to-equity ratio of 2.83, a quick ratio of 1.18 and a current ratio of 1.86. Venus Concept has a fifty-two week low of $2.16 and a fifty-two week high of $17.49. The company has a 50 day simple moving average of $3.33 and a two-hundred day simple moving average of $3.81. The company has a market capitalization of $3.53 million, a PE ratio of -0.31 and a beta of 0.25.

Venus Concept (NASDAQ:VERO) last posted its quarterly earnings data on Monday, March 31st. The company reported ($11.23) earnings per share for the quarter, missing the consensus estimate of ($10.01) by ($1.22). The firm had revenue of $15.77 million for the quarter, compared to the consensus estimate of $16.99 million.

Venus Concept Company Profile

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.